Ligand validation:4C9G

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 4C9G designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4C9G_CDL_A_802	18%	34%	0.19	0.889	1.36	1.35	4	4	4	0	37%	0.37
4C9G_CDL_A_801	9%	32%	0.217	0.808	1.28	1.51	4	5	3	0	41%	0.41
4C9G_CDL_A_800	3%	41%	0.259	0.729	1.05	1.3	1	3	1	0	25%	0.25
4C9H_CDL_A_801	22%	37%	0.189	0.91	1.2	1.37	4	5	4	0	43%	0.43
5Y5S_CDL_M_415	41%	36%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	24%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	27%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.